GERD 360°: AI, Endoscopic Innovation, and Surgical Evolution

This conference has already taken place.

This activity will address new diagnostic criteria and tools, emerging endoscopic and surgical treatments, as well as new medical and lifestyle strategies for treating esophageal disorders.  Presentations will include current diagnostic standards and technologies, like pH testing and EndoFLIP; endoscopic and surgical treatments like TIF, LINX, and Reflux Stop; as well as the opportunity for hands-on practice with these tools; and new medical therapies, including PPIs, Vonoprozan, and GLP-1s.

For pricing information, see pricing tab below.

• Additional Info
• Agenda
• Pricing
• Speakers
• Location
• Accreditation & Credit Statements

Dates and Times

Start: 1/31/2026 8:00 AM
End: 1/31/2026 4:00 PM

Objectives

At the conclusion of this activity, learners will be able to:
1. Apply updated diagnostic criteria to improve evaluation of esophageal disorders.
2. Differentiate between endoscopic and surgical interventions based on clinical indications.
3. Integrate current evidence on medical therapies into individualized treatment plans.
4. Evaluate the potential of AI technology to enhance GERD diagnosis and care.

Agenda

Pricing

Tier	Price
Physician attending in person	$0.00
Physician participating online	$0.00
Non-physician attending in person	$0.00
Non-physician participating online	$0.00

Speakers

• Gokulakrishnan Balasubramanian, MD
  • Acid Suppression in GERD: Optimizing PPI Therapy & Minimizing Harm
• Jordan Burlen, MD
  • Modern Management of Peptic Strictures: Techniques, Tools, & Tailored Therapy
• Subhankar Chakraborty, MD
  • Looking Deeper: How EndoFLIP & MiVue are Redefining GERD Diagnosis
• Megan Chan, MD
  • Beyond PPIs: Evaluating Vonoprazan in the Modern Management of GERD
• Kelly Haisley, MD
  • Beyond Biopsy: Novel Technologies for Diagnosing & Risk-Stratifying Barrett’s Esophagus
  • What to Expect When You’re Expecting: Anti-Reflux Surgery for LPR
• Alexandra Johns, MD
  • Precision Acid Testing: Defining Best Practices for GERD Evaluation
• Kyle Perry, PTA
  • Next-Gen GERD Surgery: Magnetics, Implants, & Robotics
  • Reflux Reimagined: The Promise of AI in GERD Diagnosis & Care
• Raj Shah, MD
  • Endoscopic Bariatric Therapies in GERD & Obesity: A Dual-Targeted Approach
• Jacob Skeans, MD
  • Beyond RFA: What’s Next in Barrett’s Treatment?
• Adam Spandorfer, MD
  • From Montreal to Lyon: Evolving the Framework for GERD Diagnosis
• Eric Swei, MD
  • Endoscopic Anti-Reflux Therapies: Where Are We Now?
• Patrick Sweigert, MD
  • GLP-1 Mediated Weight Loss in GERD: Mechanisms, Benefits, & Risks

Location

The Ohio State University Wexner Medical Center
Biological Research Tower
460 W. 12th Avenue, Room 115
Columbus, OH 43210

Accreditation Statement

The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The Ohio State University designates this live activity for a maximum of 5.50 AMA PRA Category 1 Credit(s) ^™. Physicians should only claim credit commensurate with the extent of their participation in the activity.